Azitra (AZTR) News Today $0.16 0.00 (-2.32%) Closing price 08/8/2025 04:10 PM EasternExtended Trading$0.16 0.00 (0.00%) As of 08/8/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock AZTR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Azitra Inc Approves Increase in Common Stock SharesJuly 3, 2025 | tipranks.comAzitra, Inc.: Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton SyndromeJune 17, 2025 | finanznachrichten.deAzitra Reports Promising Safety Data from Phase 1b Trial in Netherton SyndromeJune 17, 2025 | prnewswire.comAzitra, Inc. Announces Presentation at the 2025 BIO International ConventionJune 10, 2025 | prnewswire.comAzitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated RashMay 28, 2025 | prnewswire.comAZTR: ATR-04 Trial to Dose 1st Patient Mid-2025May 21, 2025 | finance.yahoo.comAzitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated RashMay 14, 2025 | prnewswire.comAzitra, Inc. Announces Q1 2025 Results and Provides Business UpdatesMay 13, 2025 | prnewswire.comAzitra secures funding deal for dermatology treatmentsApril 26, 2025 | investing.comAzitra, Inc. to Present ATR-04 Program Update at ASCO 2025 | AZTR Stock NewsApril 25, 2025 | gurufocus.comAzitra, Inc. to Present ATR-04 Program Update at ASCO 2025April 25, 2025 | gurufocus.comAzitra enters share purchase agreement with Alumni Capital LPApril 25, 2025 | markets.businessinsider.comAzitra, Inc. to Present ATR-04 Program Update at ASCO 2025April 25, 2025 | prnewswire.comAzitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical PipelineApril 24, 2025 | prnewswire.comAzitra to Present at Microbiome Times Partnering ForumMarch 12, 2025 | prnewswire.comAZTR: Netherton Topline Expected by Year-EndMarch 3, 2025 | msn.comMaxim Group Reaffirms Their Buy Rating on Azitra Inc (AZTR)February 27, 2025 | markets.businessinsider.comAzitra, Inc. Announces Full Year 2024 Financial Results and Provides Business UpdatesFebruary 24, 2025 | gurufocus.comAzitra, Inc. Announces Full Year 2024 Financial Results and Provides Business UpdatesFebruary 24, 2025 | prnewswire.comAzitra Inc. issues new warrants in connection with stock saleFebruary 7, 2025 | msn.comAzitra sees 3.34M shares at 27.85c in registered direct offeringFebruary 5, 2025 | markets.businessinsider.comAzitra secures $930K in registered direct offeringFebruary 5, 2025 | msn.comAzitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common StockFebruary 4, 2025 | prnewswire.comAzitra, Inc. to Present at the BIO CEO & Investor ConferenceFebruary 3, 2025 | prnewswire.comAzitra, Inc. to Present at The Microcap ConferenceJanuary 27, 2025 | prnewswire.comAzitra Announces Pricing of $1.5 Million Public Offering of Common StockJanuary 15, 2025 | prnewswire.comAzitra Announces Proposed Public Offering of Common StockJanuary 14, 2025 | prnewswire.comAZTR: Planning 2nd Site for ATR-12 TrialNovember 16, 2024 | finance.yahoo.comPromising Prospects for Azitra Inc: Buy Rating Supported by Advancements in ATR-12 and ATR-04 ProgramsNovember 15, 2024 | markets.businessinsider.comAzitra, Inc. Announces Q3 2024 Financial Results and Provides Business UpdatesNovember 12, 2024 | prnewswire.comAzitra, Inc.: Azitra to Present at BIO-Europe 2024October 30, 2024 | finanznachrichten.deAzitra to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 11, 2024 | finance.yahoo.comStrong Buy Rating on Azitra Inc. for Promising Therapeutic Candidates in Oncology and Rare DiseasesSeptember 26, 2024 | markets.businessinsider.comAzitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology CongressSeptember 24, 2024 | finance.yahoo.comBuy Rating Justified by Azitra Inc’s Advances in Rare Skin Disease Treatments and Financial StabilitySeptember 20, 2024 | markets.businessinsider.comAzitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR InhibitorsSeptember 18, 2024 | finance.yahoo.comAzitra's ATR-04 Gets FDA Fast Track Designation For Skin Rash Linked To EGFR InhibitorsSeptember 18, 2024 | markets.businessinsider.comAzitra to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 7, 2024 | finance.yahoo.comAzitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton SyndromeAugust 28, 2024 | finance.yahoo.comAzitra Inc (AZTR) Receives a Buy from Maxim GroupAugust 28, 2024 | markets.businessinsider.comAZTR: First ATR-12 Patient ScreenedAugust 24, 2024 | finance.yahoo.comAzitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR InhibitorsAugust 23, 2024 | finance.yahoo.comAzitra, Inc. (AZTR)August 21, 2024 | finance.yahoo.comAzitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton SyndromeAugust 21, 2024 | businesswire.comMcCarthy’s Buy Rating on Azitra Inc: Strong Pipeline and Strategic Financial PositioningAugust 16, 2024 | markets.businessinsider.comAZTR: Get Some Skin in the GameJuly 30, 2024 | msn.comCORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public OfferingJuly 26, 2024 | finance.yahoo.comWhy Azitra Stock Is CrashingJuly 25, 2024 | benzinga.comWhy Is Azitra (AZTR) Stock Down 75% Today?July 24, 2024 | investorplace.comKSS Line Ltd. (044450.KS)July 24, 2024 | finance.yahoo.com Get Azitra News Delivered to You Automatically Sign up to receive the latest news and ratings for AZTR and its competitors with MarketBeat's FREE daily newsletter. Email Address AZTR Media Mentions By Week AZTR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZTR News Sentiment▼0.000.38▲Average Medical News Sentiment AZTR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZTR Articles This Week▼00▲AZTR Articles Average Week Get Azitra News Delivered to You Automatically Sign up to receive the latest news and ratings for AZTR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ATHA News NERV News ALVR News FLGC News PRPH News KAPA News EQ News CARM News NXTC News LPTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:AZTR) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Azitra, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Azitra With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZTR Stock Alerts